Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT
Ligand Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 187.58M | 181.49M | 167.13M | 152.42M | 133.48M | 118.31M | 131.31M | 153.59M | 186.81M | 217.87M | 219.58M | 241.67M | 240.42M | 267.68M | 277.13M | 274.65M | 251.66M | 208.41M |
Cost of Revenue | 21M | 31.34M | 37.56M | 36.39M | 27.38M | 17.89M | 10.54M | 30.48M | 41.15M | 51.84M | 52.83M | 43.2M | 40.49M | 58.72M | 62.18M | 61.93M | 56.84M | 33.89M |
Gross Profit | 166.58M | 150.14M | 129.57M | 116.03M | 106.1M | 100.43M | 120.78M | 123.11M | 145.66M | 166.02M | 166.75M | 198.48M | 199.93M | 208.95M | 214.96M | 212.72M | 194.82M | 174.52M |
Operating Income | -34.27M | -61.81M | -22.61M | -16.33M | -16.39M | 725K | 11.94M | -4.8M | -6.32M | -2.9M | -23.71M | 5.78M | 19.93M | 64.23M | 75.55M | 77.37M | 65.41M | 26.77M |
Interest Income | 5.52M | 7.81M | 8.05M | 7.82M | 8.73M | 8.3M | 7.71M | 7.04M | 5.37M | 3.35M | 2.05M | 1.21M | 789K | 724K | 886K | 1.09M | 1.91M | 3.64M |
Pretax Income | -84.5M | -161.11M | 2.52M | 58.81M | 53.01M | 121.57M | 63.66M | 70.7M | 83.7M | 79.9M | 4.22M | -26.95M | -12.54M | 21.39M | 47.3M | 57.69M | 30.82M | 25.64M |
Net Income | -75.86M | -132.62M | -4.03M | 45.24M | 42.14M | 96.34M | 52.15M | 19.43M | 30.11M | 26.92M | -30.41M | -20.84M | -7.53M | 24.09M | 57.59M | 68.31M | 47.89M | 39.25M |
Selling & General & Admin | 89.06M | 86.5M | 78.65M | 69.04M | 59.22M | 52.89M | 52.79M | 67.93M | 70.72M | 74.02M | 81.34M | 67.95M | 63.22M | 63.34M | 57.78M | 70.13M | 72.43M | 67.79M |
Research & Development | 66.75M | 65.54M | 21.43M | 22.49M | 22.34M | 23.84M | 24.54M | 28.25M | 44.75M | 57.01M | 70.66M | 79.7M | 74.61M | 71.44M | 69.01M | 72.69M | 68.6M | 65.38M |
Other Expenses | 43.77M | 68.17M | 60.35M | 32.46M | 22.13M | -13.49M | -4.95M | 11.9M | 28.02M | 40.72M | 43.99M | 47.23M | 43.44M | 9.29M | 9.27M | 9.65M | 5.5M | 31.69M |
Operating Expenses | 199.57M | 220.21M | 160.43M | 140.62M | 132.87M | 101.82M | 110.96M | 130.03M | 152.9M | 171.75M | 195.99M | 194.88M | 181.26M | 144.08M | 136.06M | 152.46M | 146.53M | 164.86M |
Interest Expense | 3.36M | 3.76M | 3.03M | 2.28M | 1.54M | 557K | 656K | 765K | 1.1M | 1.25M | 1.8M | 6.03M | 10.14M | 14.58M | 19.63M | 21.54M | 23.37M | 24.7M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 221.85M | 243.3M | 189.74M | 168.75M | 151.99M | 119.71M | 121.49M | 160.51M | 194.06M | 223.59M | 248.82M | 238.08M | 221.75M | 202.8M | 198.24M | 214.39M | 203.37M | 198.75M |
Income Tax Expense | -8.63M | -28.49M | 6.55M | 13.57M | 10.87M | 25.23M | 9.84M | 49.61M | 51.93M | 51.31M | 34.63M | -6.1M | -5.02M | -2.7M | -10.29M | -10.62M | -17.07M | -13.61M |
Shares Outstanding (Basic) | 19.26M | 19.19M | 18.97M | 18.42M | 18.03M | 17.73M | 17.47M | 17.38M | 17.28M | 17.06M | 16.89M | 16.89M | 16.87M | 16.79M | 16.73M | 16.69M | 16.66M | 16.43M |
Shares Outstanding (Diluted) | 19.26M | 19.19M | 18.97M | 18.42M | 18.03M | 18.12M | 17.68M | 17.38M | 17.73M | 17.97M | 16.89M | 17.13M | 16.87M | 16.82M | 16.73M | 17.14M | 17.17M | 17.25M |
EPS (Basic) | -3.99 | -7.12 | -0.05 | 2.63 | 2.28 | 5.29 | 2.89 | 0.99 | 1.75 | 1.57 | -1.81 | -1.25 | -0.45 | 1.44 | 3.46 | 4.12 | 2.88 | 2.42 |
EPS (Diluted) | -3.98 | -7.12 | -0.16 | 2.51 | 2.16 | 5.17 | 2.75 | 0.86 | 1.62 | 1.44 | -1.8 | -1.24 | -0.46 | 1.38 | 3.34 | 3.99 | 2.77 | 2.30 |
EBITDA | -57.12M | -122.11M | 40.79M | 96.63M | 89.7M | 157.94M | 49.79M | 58.09M | 87.47M | 87.39M | 88.96M | 64.91M | 63.58M | 74.62M | 76.65M | 93.87M | 68.56M | 55.95M |
EBIT | -83.51M | -157.35M | 5.55M | 61.1M | 54.55M | 122.13M | 22.75M | 29.9M | 54.73M | 60.37M | 37.81M | 51.12M | 50.34M | 52.88M | 65.95M | 38.02M | 20.77M | 43.46M |
Depreciation & Amortization | 26.39M | 35.24M | 35.24M | 35.53M | 35.15M | 35.81M | 36.61M | 37.76M | 42.65M | 46.23M | 50.31M | 53.18M | 52.29M | 51.5M | 50.95M | 50.81M | 42.75M | 34.68M |